Zenith® p-Branch® Endovascular Graft Pivotal Study

Trial ID or NCT#

NCT02396199

Status

not recruiting iconNOT RECRUITING

Purpose

The Zenith® p-Branch® Pivotal Study is a clinical trial approved by FDA to study the safety and effectiveness of the Zenith® p-Branch® endovascular graft in combination with the Atrium iCAST™ covered stents in the treatment of abdominal aortic aneurysms.

Official Title

Zenith® p-Branch® Pivotal Study

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Pararenal or juxtarenal AAA ≥5.0 cm in diameter or 2 times the normal aortic diameter* Pararenal or juxtarenal AAA with history of growth ≥0.5 cm/year* Saccular aneurysm with aortic diameter greater than 1.5 times the normal aortic diameter that is deemed to be at risk for rupture based upon physician interpretation
Exclusion Criteria:
  1. * Age \<18 years* Life expectancy \<2 years* Pregnant, breast-feeding, or planning on becoming pregnant within 60 months* Inability or refusal to give informed consent by the patient or a legally authorized representative* Unwilling or unable to comply with the follow-up schedule* Simultaneously participating in another investigative device or drug study. (The patient must have completed the primary endpoint of any previous study at least 30 days prior to enrollment in this study.)* Additional medical restrictions as specified in the Clinical Investigation Plan* Additional anatomical restrictions as specified in the Clinical Investigation Plan
View All Criteria
Show Less

Investigator(s)

Venita Chandra
Venita Chandra
Vascular surgeon
Clinical Professor, Surgery - Vascular Surgery Clinical Professor (By courtesy), Neurosurgery
Jason T. Lee, MD
Jason T. Lee, MD
Vascular surgeon
Professor of Surgery (Vascular Surgery)

View on ClinicalTrials.gov